UNSPSC 51192100: Combination antigout agents

This classification denotes combination drugs that increase uric acid excretion by the kidney, decrease uric acid production, or alleviate the pain and inflammation of acute attacks of a hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia, and deposition of sodium urate, called GOUT, hence the term ANTIGOUT AGENTS. Typical combination antigout agent constituents are colchicine and probenecid.

UNSPSC 51192100 Combination antigout agents is a Class code that in recent state and local procurement activity covers athletic training services, first-aid and medical supply provision, and pharmacy benefit program administration — a scope substantially broader than the code's nominal name suggests. The discrepancy between the code's pharmaceutical framing and the actual work being solicited reflects how state and local agencies tag opportunities: the three recent solicitations on file show the code applied to occupational health services, emergency medical consumables, and health plan operations rather than antigout medications specifically. Issuing bodies include municipal governments (the City of Tucson, the City of Tampa) procuring injury prevention and first-aid support for public safety departments, and a state health agency (the Texas Health and Human Services Commission) managing pharmacy benefit strategy. The mix suggests the code sees use across cities, specialized health agencies, and fire-rescue departments rather than a concentrated buyer base.

Recent activity spans Arizona, Florida, and Texas. The City of Tucson posted RFP 260163 in May 2026 (due June 9, 2026) for comprehensive athletic training services for the Fire Department and Police Department, requiring NATA BOC and NSCA TSAC-F certification, physician supervision, and injury prevention, fitness, treatment, and rehabilitation delivery. The City of Tampa issued ITB 25-P-00157 in April 2026 for medical aid supplies — antiseptic sprays, pain relievers, bandages, first-aid kits, and emergency blankets — with a $100,000 annual budget and 5% bid discounts for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting and outcomes-based agreements outside traditional pharmacy benefit manager arrangements.